Navigation Links
Ocular Therapeutix, Inc. Completes Series D Financing to Support Phase II Sustained Drug Delivery Clinical Trials
Date:2/2/2011

Therapeutix, Inc. is a privately held company based in Bedford, MA focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology. Ocular Therapeutix's first product, the ReSure™ Adherent Ocular Bandage, is CE Mark Approved and commercially available outside the United States. Ocular Therapeutix has also developed sustained ocular drug delivery depots using its hydrogel punctum plug technology, of which it plans to enter Phase II clinical trials in 2011.

About Ascension Health Ventures:

Ascension Health Ventures was launched in 2001 as a wholly-owned subsidiary of Ascension Health. AHV's role has been to construct and manage a strategic portfolio of investments that deliver a venture investment return, have the potential to transform the healthcare industry and significantly enhance the quality of patient care. CHV II, LP, a limited partnership between Ascension Health, Catholic Health Initiatives, Catholic Health East and Catholic Healthcare West, has been formed to expand this strategic investment initiative to other Catholic healthcare systems. AHV is the general partner of CHV II, LP.


'/>"/>
SOURCE Ocular Therapeutix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ocular Therapeutix Completes Proof of Principle Study with Moxifloxacin-Loaded Punctum Plugs
2. Sylentis Completes Phase I Trial with SYL040012 to Treat Elevated Intraocular Pressure and Glaucoma
3. Tekia Enters Into Distribution Agreement With Fritz Ruck/T-MED, Germany to Market Its Accommodative Intraocular Lens to Treat Presbyopia
4. Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes
5. Quark Announces Dosing of the First Patient in Phase I Clinical Trial of its Ocular Neuroprotective Agent, QPI-1007
6. Ocular Therapeutix, Inc. Appoints Two New Board Members
7. ISTA Pharmaceuticals Bepreve(TM) Receives FDA Approval for the Treatment of Ocular Itching Due to Allergies
8. Study of Lacrisert(R) Dry Eye Insert Published in The Ocular Surface
9. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
10. SARcode and Sunesis Announce Start of Phase 1 Clinical Trial in Ocular Inflammatory Diseases
11. PLC Systems Completes Sale of TMR Business to Novadaq
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... , Mar. 26, 2015 Research and ... the addition of the "Marine Biotechnology - ... offering. Annual estimates and forecasts are ... a seven-year historic analysis is provided for these ... primary and secondary research. This report ...
(Date:3/30/2015)... SAN DIEGO , March 30, 2015 /PRNewswire/ ... announced that Tom Cannell has joined ... for global commercialization of Contrave® /Mysimba™ (naltrexone HCl ... all aspects of Orexigen,s global commercial strategy, assuming ... After successfully leading Orexigen,s commercial effort through the ...
(Date:3/30/2015)... 30, 2015 NiQ Health, ... announced the high level interface capabilities of their ... systems. The partnership between CarePlus™ and ... this allows patients to choose the most appropriate ... acuity. The advanced functionality of CarePlus™ allows patient ...
Breaking Medicine Technology:Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 2Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 3Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 4Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 5Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 6Marine Biotechnology - Global Strategic Business Report 2015-2020: Polysaccharides from Marine Microalgae Holds Tremendous Potential 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 2Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 3Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 4Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 5Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 6Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 7Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 8Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 9Orexigen Therapeutics Announces that Tom Cannell has Joined As Chief Commercial Officer 10NiQ Health Announces CarePlus(TM) Integration with ClinicAll 2
... -- WuXi PharmaTech (NYSE: WX ), ... development outsourcing company, with operations in China and ... in a negotiated transaction agreed to purchase from ... Atlantic LLC ("General Atlantic") all of the WuXi ...
...  Mercy Jets has announced it will make contributions to ... of Heart Month, the  air ambulance  transportation and medical ... and heart-related health. While the  medical transport ... non-profit organizations, Mercy Jets will donate twice that amount ...
Cached Medicine Technology:WuXi PharmaTech Announces Purchase of Ordinary Shares from General Atlantic 2Mercy Jets Celebrates Heart Month With Charitable Donations 2
(Date:3/30/2015)... March 31, 2015 NAPW ... Professional Woman of the Year. Ms. Irey is recognized ... the largest, most-recognized networking organization of professional women in ... National Association of Professional Women is a powerfully vibrant ... Local Chapters. , “I take care of four offices, ...
(Date:3/30/2015)... March 31, 2015 The AAAHC, ... advocate for the provision of high-quality health care ... its survey and accreditation programs for 35 years. ... AAAHC aims to promote excellence in patient safety ... rigorous self-assessments and on-site evaluations by AAAHC expert ...
(Date:3/30/2015)... Healthpointe is proud to provide urine ... companies throughout Southern California. The drug screen determines ... It can identify evidence of recent use of alcohol, ... applicants, and students regularly choose Healthpointe as their drug ... drug screen program at Healthpointe include:, , ...
(Date:3/30/2015)... San Diego, CA (PRWEB) March 30, 2015 ... provider, is proud to announce the start of its ... and bestselling author Jane McGonigal, and former Congressman Patrick ... In Recovery Conference being held in San Diego, ... Hotel Del Coronado. The national conference brings together leading ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 The pharmaceutical ... and flexible biological manufacturing plants. This is primarily due ... business. , This has forced facilities to produce and ... The existing facilities have been forced to expand production, ... change of ownership. , Most of these facilities have ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Announces Stacey Lynne Irey, Office Manager at Mid Jersey Endodontic Group, a 2015 Professional Woman of the Year 2Health News:Precinct Ambulatory Surgery Center Achieves Accreditation Association for Ambulatory Health Care Accreditation 2Health News:Drug Screens Now at Healthpointe 2Health News:Drug Screens Now at Healthpointe 3Health News:Foundations Recovery Network Kicks Off Its 41st National Conference Specializing in the Treatment of Substance Abuse and Behavioral Health 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 3
... May 6 Rigel,Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... 31, 2008., During the first quarter of 2008, ... per share, compared to a net loss of $17.1 ... 2007. Weighted average shares,outstanding for the first quarters of ...
... ... Labs Nationwide, ALISO ... a premier anatomic pathology and molecular testing services,resource for pathologists, ... a one-year agreement with Joint Venture,Hospital Laboratories (JVHL) to provide ...
... Fla., May 6 The common practice of clipping a,pet ... house may be causing,more serious emotional trauma to pet birds ... rights., Thousands of pet parrots are developing psychological problems ... fly stripped away from,them from unknowing pet owners., This ...
... Health Plan,Inc., Kaiser Foundation Hospitals and their subsidiaries (KFHP/H) ... quarter ended,March 31, 2008, compared to $9.4 billion in ... quarter of this year was $250 million versus $698,million ... the first quarter,increased slightly to $545 million from $521 ...
... of More Than 40,000 Readers Gives High Marks To ... Evolving,Consumer-Pharmacist Relationship, YONKERS, N.Y., May 5 For ... drugs out of pocket, a new price,study by Consumer ... only do,prices vary from store to store for the ...
... Provide Deloitte the Opportunity to Respond to,Specific Solicitations ... May 5 Deloitte has been awarded the,opportunity ... (DoD) Military,Health System (MHS) to provide strategy, operations ... and Management Support (TEAMS),contract is a multiple-award vehicle ...
Cached Medicine News:Health News:Rigel Announces First Quarter 2008 Financial Results 2Health News:Rigel Announces First Quarter 2008 Financial Results 3Health News:Rigel Announces First Quarter 2008 Financial Results 4Health News:Clarient Partners With Joint Venture Hospital Laboratories to Offer Pathologists Wide Array of Cancer Assays 2Health News:Clarient Partners With Joint Venture Hospital Laboratories to Offer Pathologists Wide Array of Cancer Assays 3Health News:Clarient Partners With Joint Venture Hospital Laboratories to Offer Pathologists Wide Array of Cancer Assays 4Health News:How Clipping Pet Parrot's Wings May Violate Their Animal Rights 2Health News:Kaiser Foundation Health Plan and Hospitals Reports First Quarter 2008 Financial Results 2Health News:Kaiser Foundation Health Plan and Hospitals Reports First Quarter 2008 Financial Results 3Health News:Consumer Reports: Some Drug Prices Can Vary By $100 or More for the Same Bottle of Pills 2Health News:Consumer Reports: Some Drug Prices Can Vary By $100 or More for the Same Bottle of Pills 3Health News:Consumer Reports: Some Drug Prices Can Vary By $100 or More for the Same Bottle of Pills 4Health News:Consumer Reports: Some Drug Prices Can Vary By $100 or More for the Same Bottle of Pills 5Health News:Deloitte Awarded Opportunity to Respond to Military Health System Contracts 2
... VERSASTEP™ Plus Short Instrument ... , ,The VERSASTEP™ Plus ... Working Length is a unique ... applications in laparoscopic procedures. It ...
... Trocar consists of a blunt obturator connected ... assembly. , ,The valve body assembly ... to prevent gas leakage when instruments are ... Trocar includes built-in converters to allow insertion ...
... Premium One-Step™ single-use system device is comprised ... device components for creating each access port ... , Step™ insufflation and access needle, ... separately. , Step™ radially expandable sleeve, 100 ...
... contains an internal seal to prevent gas leakage ... of pneumoperitoneum. The 5 mm PLUS system includes ... mm - 12 mm as appropriate and is ... of the trocar to allow insertion of smaller ...
Medicine Products: